Therapeutic Goods Act 1989: Act Number and Citation Basics

1. Key takeaways

The Act number of the Therapeutic Goods Act 1989 is Act No. 21, 1990, not “21 of 1989”. The mismatch between the year in the title and the year in the number is not an anomaly but a consequence of the legislative timeline: the Act received royal assent on 17 January 1990 and commenced in full on 15 February 1991. Citing the number incorrectly is one of the most common first-instance errors found in Australian compliance documents. Because the number appears in contracts, submissions, declarations, and correspondence with the regulator, a wrong citation propagates through an entire document set and undermines the credibility of an otherwise sound regulatory position. Fixing the citation convention once, at the level of a house style rule, removes this entire class of error permanently. The correction also has a practical reading benefit: readers who see both years immediately understand that the long commencement timeline is the explanation, rather than suspecting a drafting mistake that must be investigated before the substance of the document can be trusted.

2. Legal basis

1. Therapeutic Goods Act 1989; Act No. 21, 1990; Federal Register of Legislation ID C2004A03952; royal assent on 17 January 1990; section 2 provides that the Act commences in full on 15 February 1991.
2. Current compilation: C2025C00525 (C89); registered on 18 September 2025, effective on 5 September 2025.
3. The significant amendment that triggered this compilation: the Health Legislation Amendment (Improved Medicare Integrity and Other Measures) Act 2025, Act No. 38, 2025, registration number C2025A00038; royal assent on 4 September 2025, with Schedule 2 commencing on 5 September 2025.
4. The previous therapeutic-goods-specific amendment Act: the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024, Act No. 50, 2024, registration number C2024A00050; royal assent on 27 June 2024, with Schedule 1 commencing on 1 July 2024.
5. Core medical device provisions: section 41BD (definition of medical device), section 41BE (devices of the same kind), section 41BH (determination of compliance with the Essential Principles), section 41FN (automatic conditions of inclusion), and section 9A (establishment of the ARTG). These are the provisions most frequently engaged in device work, and each of them has generated interpretive practice that depends on the exact statutory text, which is another reason the compilation must always be cited alongside the section number.

3. Expert insights

Insight 1: The number mismatch is not a typo; it is an institutional outcome. Australian legislation is labelled on a dual track of title year plus number year, and an assent that crosses a calendar year produces the offset. In our deliverables we consistently write Therapeutic Goods Act 1989 (Act No. 21, 1990), making both years explicit so that readers do not mistake the citation for an error. This small convention carries real weight: reviewers, auditors, and opposing consultants all judge the quality of a regulatory dossier by its citations, and an unexplained year mismatch invites unnecessary challenges that consume review time without adding value.

Insight 2: The compilation number carries more information than “latest version”. Citing the current version generically cannot fix a point in time when a dispute arises; stating C89 with an effective date of 5 September 2025 anchors the legal status of the document, in the same way that a version pin anchors a software build. The same logic applies on the Regulations side, where the current compilation is C72. When a provision is later substituted, the anchor makes it immediately clear which text governed at the relevant time, and the comparison between the two texts becomes a routine exercise rather than an archaeological one.

Insight 3: An amendment Act unrelated to devices can still touch device provisions. The compilation C89 was triggered by the Medicare integrity Act, whose Schedule 2 nevertheless reached therapeutic goods provisions. This illustrates the piggyback amendment pattern that is common in Australian legislative practice: monitoring only Acts whose titles contain device-specific language will miss actual changes. A tracking process built on title keywords alone is therefore structurally incomplete, and teams relying on it operate with a blind spot that surfaces only when a provision has already shifted underneath an approved document set.

4. Practical recommendations

1. Adopt a single citation format across all outward-facing documents: Therapeutic Goods Act 1989 (Act No. 21, 1990), compilation C2025C00525, effective 5 September 2025. Applying the format uniformly removes ambiguity and makes internal review faster.
2. Maintain an amendment tracking log that covers not only amendment Acts whose titles contain “Therapeutic Goods” but also the Schedule lists of piggyback amendments carried in unrelated Acts, so that the log reflects the real amendment landscape. Assigning ownership of the log matters as much as building it, because an unowned tracker decays within a quarter and the blind spot returns silently.
3. After each compilation update, compare the previous version’s Endnote 3 (amendment history) to locate the provisions that actually changed, and then assess the impact on products already on the market before updating any submission documents.
4. For projects that span calendar years, fix a legal version baseline date in contracts and submission documents, so that version drift during a long review cycle cannot generate disputes about which text applied when commitments were made. A single dated sentence in the governing document is usually sufficient, provided every party uses the same compilation reference.

5. Verification checklist

• □ Citations state the Act number as Act No. 21, 1990 and do not write 21 of 1989
• □ The current compilation number and effective date are cited (C2025C00525, effective 5 September 2025)
• □ The distinction between the assent date of 17 January 1990 and the full commencement date of 15 February 1991 has been confirmed
• □ The amendment tracking log covers piggyback amendment Acts
• □ Project documents have fixed a legal version baseline date

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Australian market. Our team manages TGA inclusion and ARTG listing applications, coordinates conformity assessment evidence, and supports post-market vigilance obligations. Business enquiries: info@grzan.cn